METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

HUMAN TISSUE DERIVED COMPOSITIONS AND USES THEREOF

METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR)

FORMULATION OF LONG-ACTING LEVONORGESTREL BUTANOATE INJECTABLE DEPOT SUSPENSION

TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND FULVESTRANT

COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE

EXATECAN FORMULATION

MULTIMERIZER PHARMACEUTICAL COMPOSITIONS

USES OF BUPIVACAINE MULTIVESICULAR LIPOSOMES AS STELLATE GANGLION BLOCK FOR TREATING DISORDERS ASSOCIATED WITH SYMPATHETIC NERVOUS SYSTEM

Microsphere-Based Injectable Celecoxib Formulation

USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION

LIPID EMULSIONS AND USES THEREOF

LIQUID FORMULATION COMPRISING A FUSION PROTEIN INCLUDING a-GALACTOSIDASE A

Products and Methods for Treatment of Amyotrophic Lateral Sclerosis

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS

PEPTIDE ANALOGS

TREPROSTINIL PRODRUGS

METHOD FOR THE TREATMENT OF VASCULAR ANOMALIES BY ADMINISTERING ONE OR MORE SCLEROSING AGENTS AND APPLYING A SERIES OF ELECTRIC PULSES

MATERIALS AND METHODS FOR THE TREATMENT OF LIMB GIRDLE MUSCULAR DYSTROPHY

COMPOSITION AND METHODS FOR TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY

LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

COMBINATION THERAPY COMPRISING AN ANTI-IL-23 ANTIBODY AND A CORTICOSTEROID FOR TREATING PSORIASIS

CORONAVIRUS VACCINE

NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS

PHARMACEUTICAL FORMULATIONS

SEMAGLUTIDE FOR USE IN MEDICINE

Mutant Peptides And Methods Of Treating Subjects Using The Same

Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

LINEZOLID FORMULATIONS

Stabilizing Camptothecin Pharmaceutical Compositions

INJECTABLE FORMULATION COMPRISING ISOXAZOLINE DERIVATIVE AND METHOD FOR PREPARING SAME

BIOMARKERS FOR NANOPARTICLE COMPOSITIONS

DOCETAXEL COMPOSITIONS AND METHODS

SOTALOL HYDROCHLORIDE DOSING

METHOD OF ESCALATING SOTALOL HYDROCHLORIDE DOSING

METHODS OF ADMINISTERING THERAPEUTIC AGENTS TO THE SUBRETINAL SPACE

EGFL6 SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

ANTI-APOE ANTIBODIES

METHODS FOR TREATING COMPLEMENT-MEDIATED DISEASES AND DISORDERS

METHODS FOR MODULATING AN IMMUNE RESPONSE

DANTROLENE PRODRUGS AND METHODS OF THEIR USE

ALBUMIN CONJUGATES AND RADIOPHARMACEUTICAL COMPOSITION THEREOF

CARBON NANOPARTICLE SUSPENSION INJECTION-FE, PREPARATION METHOD, APPLICATION AND USE METHOD

INJECTABLE COMPOSITION

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

COMPOSITION AND METHODS FOR REGULATING CHONDROCYTE PROLIFERATION AND INCREASING OF CARTILAGE MATRIX PRODUCTION

PEPTIDE HORMONE TO PREVENT OR TREAT VASOSPASM, BRAIN INJURY OR CEREBRAL EDEMA

ANTI-FIBROTIC SIALIDASE INHIBITOR COMPOUNDS AND METHODS OF USE

iRGD-ANALOGS AND RELATED THERAPEUTIC METHODS

GLYCAN STRANDS AND OLIGOSACCHARIDES DERIVED FROM STREPTOCOCCUS BACTERIA

PHARMACEUTICAL COMPOSITION FOR TREATING RETINITIS PIGMENTOSA

BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION

MELFLUFEN DOSAGE REGIMENS FOR CANCER

Guiding Musculoskeletal Procedures

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

miR-141-3p MODULATORS AND USES THEREOF

METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE

ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1 THAT ARE PD-1 AGONISTS

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

PHARMACEUTICAL COMPOSITION COMPRISING ADIPOSE TISSUE-DERIVED EXTRACELLULAR VESICLE AND BIOLOGIC AND USE OF PHARMACEUTICAL COMPOSITION FOR TREATING ARTHRITIS

METHODS FOR MODULATING AN IMMUNE RESPONSE

YTTRIUM [90Y] MICROSPHERE AND PREPARATION METHOD THEREFOR AND USE THEREOF

TREATMENT OF HR+/HER2- BREAST CANCER USING SACITUZUMAB GOVITECAN

COMBINATION THERAPIES FOR TREATING CANCERS

COMPOSITIONS COMPRISING STEROL-AMINO-PHOSPHATE COMPOUNDS AND METHODS OF MAKING AND USE THEREOF

COMPOSITIONS AND METHODS FOR GENERATING TICK IMMUNITY

PHARMACEUTICAL FORMULATIONS AND METHODS OF MAKING THE SAME

THERAPEUTIC VITAMIN D CONJUGATES

PROMININ-1 PEPTIDE FOR TREATING LUNG INJURY

METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

A COMBINATION COMPOSITION

Arterial Application of Low Dose Ethyl Alcohol Enables Blood-Brain Barrier (BBB) Transient Opening

Modified Bont/A for Use in the Treatment of Cervical Dystonia

Method of Treating Psoriasis with Anti-IL23 Specific Antibody

Phenethylamines and cathinones precursors

TRYPTAMINE PRODRUGS

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

METHOD FOR INHIBITING ZOPHOBAS MORIO BLACK WASTING DISEASE

Hyaluronidase Enzyme Formulations for High Volume Administration

Hyaluronidase Enzyme Formulations for High Volume Administration

INSULIN FORMULATIONS AND USES IN INFUSION DEVICES

DAPTOMYCIN FORMULATIONS

COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF

FORMULATION OF A RILUZOLE SOLUTION WITH BETA-CYCLODEXTRINS

USE OF CARBAMATE COMPOUND FOR PREVENTING, ALLEVIATING OR TREATING MYOTONIA

NOVEL NAPROXEN SODIUM PREPARATIONS FOR PARENTERAL ADMINISTRATION

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY

VIRAL VECTORS AND PACKAGING CELL LINES

VIRAL VECTORS AND PACKAGING CELL LINES

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

SELECTIVE AND POTENT INHIBITORY ANTIBODIES OF MYOSTATIN ACTIVATION

USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA

GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES

GIP/GLP1 CO-AGONIST COMPOUNDS

APPARATUS AND METHOD FOR ULTRASOUND SPINAL CORD STIMULATION

STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE

INJECTABLE PREPARATION

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

MRNA THERAPEUTIC COMPOSITIONS

LYOPHILIZED FACTOR IX FORMULATIONS

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

CONTROLLED RELEASE PEPTIDE FORMULATIONS

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

USE OF LINK-TSG6 FOR THE TREATMENT OF OSTEOARTHRITIC PAIN

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

BIOMARKERS OF METHOTREXATE-INDUCED IMMUNE TOLERANCE

TREATMENT OF RESTENOSIS USING TEMSIROLIMUS

COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND VALPROIC ACID AND USES THEREOF

PHARMACEUTICAL COMPOSITION

EPINEPHRINE COMPOSITIONS AND CONTAINERS

Method and Apparatus for Drug Delivery to Surgical Margins

SEQUENTIAL APPLICATION OF MACROPHAGES FOR WOUND HEALING

DOSING OF A BISPECIFIC ANTIBODY THAT BINDS PD1 AND CTLA4

PHARMACEUTICALS AND DEVICES FOR THE COVALENT IMMOBILIZATION TO THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE

CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF

Azaindole rock inhibitors

SULFOXIMINE GLYCOSIDASE INHIBITORS

ANTIBACTERIAL AGENTS: SOLUBLE SALTS AND AQUEOUS FORMULATIONS OF PYRONINS

METHOD FOR TREATING TUMOR USING IMMUNE CELL

VISTA ANTAGONIST AND METHODS OF USE

COMPOSITION FOR LIPOLYSIS COMPRISING EXTRACT OF MORUS ALBA L. BARK AND MAGNOLIA OFFICINALIS BARK AS ACTIVE INGREDIENT

Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICRENVIRONMENT

LONG-ACTING LIPOSOMAL COMPOSITION FOR TREATMENT OF PAIN IN ARTICULAR DISORDERS

ADMINISTRATION OF A PSYCHEDELIC COMPOUND BY INTRAVENOUS INFUSION

METHODS OF TREATING CANCER WITH AN MTOR INHIBITOR

ALS TREATMENT USING INDUCED REGULATORY T (ITREG) CELLS

REGIMENS FOR TREATING HIV INFECTIONS AND AIDS

Ifetroban Treatment for Systemic Sclerosis

MICROSPHERES FOR EXTENDED RELEASE OF FENOFIBRATE

CONTINUOUS ADMINISTRATION OF L-DOPA, DOPA DECARBOXYLASE INHIBITORS, CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND COMPOSITIONS FOR SAME

NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE

METHODS FOR ALTERING BODY COMPOSITION BY ADMINISTERING A GDF8 INHIBITOR AND AN ACTIVIN A INHIBITOR

MEDICATION INFUSION COMPONENTS AND SYSTEMS

TERAGNOSTIC METHOD FOR CANCER PATIENTS

Lipid Nanoparticle Compositions and Methods for mRNA Delivery

Zonal and Targeted Methods and Uses for Treating a Post-Traumatic Stress Disorder

ACETYL SALICYLIC ACID COMPOSITION FOR INTRAVENOUS ADMINISTRATION, ITS STORAGE, PRODUCTION AND USE

ARIPIPRAZOLE FORMULATIONS HAVING INCREASED INJECTION SPEEDS

USE OF LACTIC ACID IN PRODUCT FOR REGULATING AND PROMOTING TISSUE GROWTH

MICROPARTICLE FORMULATIONS FOR INTRAVENOUS THERAPY AND METHODS FOR THEIR MANUFACTURE AND USE

INJECTABLE FORMULATION CONTAINING ISOXAZOLINE DERIVATIVE

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

METHODS, COMPOSITIONS AND DOSING REGIMENS FOR TREATING OR PREVENTING INTERFERON-GAMMA RELATED INDICATIONS

MORPHIC FORMS OF TRILACICLIB AND METHODS OF MANUFACTURE THEREOF

CONSTRAINED AMINE PSYCHOPLASTOGENS AND USES THEREOF

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES

Analgesic Therapeutics Based on Conjugation of Biocompatible Polymers to Ion Channel Modulators

HYDROGEL-BASED DELIVERY SYSTEM FOR INDUCTION OF INTRATUMORAL TERTIARY LYMPHOID STRUCTURES AND AUGMENTATION OF IMMUNE CHECKPOINT BLOCKADE AND METHODS THEREOF

FORMULATIONS

RESPIRATORY SYNCYTIAL VIRUS VACCINE

STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS

ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

THERMOSTABLE FORMULATION OF A21G HUMAN INSULIN

METHODS FOR TREATING STROKE USING A STANNIOCALCIN 2 (STC2) PHARMACEUTICAL COMPOSITION

SATIATION PEPTIDE ADMINISTRATION

Reconstituted HDL Formulation

CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING

PREVENTION OR TREATMENT OF CARDIOVASCULAR DISEASES WITH HIGH PENETRATION PRODRUGS OF ASPIRIN AND OTHER NSAIDS

ABIRATERONE PRODRUGS

STABLE ANTIEMETIC EMULSIONS

ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF

TREATMENT OF DIABETIC RETINOPATHY USING ENDOTHELIN RECEPTOR ANTAGONISTS

Analgesic Therapeutics Based on conjugation of Biocompatible Polymers to Ion Channel Modulators

INJECTABLE SLURRIES AND METHODS OF MANUFACTURING THE SAME

METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS

METHODS OF TREATING HEMOPHILIA A

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

Azaindole rock inhibitors

CNP PRODRUGS

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN AGONIST RECEPTOR OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID

TREATMENT OF INTERVERTEBRAL DISC DEGENERATION

ALLEVIATING DRUG NEPHROTOXICITY

MODULATORS OF COMPLEMENT ACTIVITY

ANGIOTENSIN COMPOSITIONS AND METHODS RELATED THERETO

METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS AT HIGH RISK OF POOR OUTCOMES

INJECTABLE COMPOSITION COMPRISING CYTOLYTIC COMPOUND IN GEL, GEL-FORMING SOLUTION OR GEL-FORMING SUSPENSION FOR REDUCTION OF FAT

METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES

CDC7 Inhibitor Combinational Therapy

SUCCINYLCHOLINE PREFILLED SYRINGE, COMPOSITIONS AND METHODS

FORMULATIONS AND DOSES OF PEGYLATED URICASE

RECOMBINANT CLUSTERIN AND USE THEREOF IN THE TREATMENT AND PREVENTION OF DISEASE

TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39)

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE VISUAL AND AUDITORY SYSTEMS

PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY

THERAPEUTIC AGENTS FOR TREATMENT OF CORONAVIRUS INFECTION

Drugs for prevention or treatment of sepsis

NUCLEOSIDE FORMULATION

GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS

COMPOSITIONS AND METHODS FOR TREATMENT, AMELIORATION, AND PREVENTION OF ANESTHESIA-INDUCED HYPOTHERMIA

Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin

INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES

ADENOASSOCIATED VIRUS VECTORS FOR THE TREATMENT OF MUCOPOLYSACCHARIDOSES TYPE IV A

STABLE FORMULATIONS OF ANTI-CTLA4 ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

METHOD OF PRODUCING PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOGENIC CHIKUNGUNYA VIRUS CHIKV-DELTA5NSP3

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS

TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST

PSILOCIN BENZOATE FORMULATION FOR INTRAVENOUS INFUSION

DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS

DRUG FOR CORRECTION OF MITOCHONDRIAL DYSFUNCTION

REDUCTION OF ADIPOSE TISSUE

Sustained Release Olanzapine Formulations

A STABLE INJECTABLE COMPOSITION OF TRIAMCINOLONE ACETONIDE

MEANS AND METHOD FOR PREPARING VIRAL VECTORS AND USES OF SAME

CATALYTICALLY INACTIVE CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PAIN & INFLAMMATORY DISORDERS

AUTOMATED PRODUCTION OF VIRAL VECTORS

LIPOSOME ENCAPSULATED AFFINITY DRUG

METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR

POLYPEPTIDE AND APPLICATION THEREOF IN PREPARATION OF ANTI-FIBROSIS DRUG

PD-L1 INHIBITORY PEPTIDE FOR CANCER IMMUNOTHERAPY

RADIOPHARMACEUTICALS, RADIOIMAGING AGENTS, AND USES THEREOF

VANIN-1 INHIBITORS

PARP7 INHIBITORS

Sodium thiosulfate-containing pharmaceutical compositions

AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENTS

NUCLEIC ACID MOLECULES AND USES THEREOF

Nucleoside-modified RNA for Inducing an Adaptive Immune Response

NEUROTOXIN COMPOSITIONS FOR USE IN TREATING DIGESTIVE DISORDERS

INJECTABLE BOTULINUM TOXIN FORMULATIONS AND METHODS OF USE THEREOF HAVING HIGH RESPONSE RATE AND LONG EFFECT DURATION

USE OF LYSIN TO RESTORE/AUGMENT ANTIBACTERIAL ACTIVITY IN THE PRESENCE OF PULMONARY SURFACTANT OF ANTIBIOTICS INHIBITED THEREBY

COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORM

PREVENTION OF PROGRESSIVE HEART FAILURE

THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA

SELF-ADMINISTRATION INJECTION DEVICE FOR RISPERIDONE

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS USING PKC ACTIVATORS

AQUEOUS FORMULATION COMPRISING PARACETAMOL AND IBUPROFEN

NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS

AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

METHODS AND COMPOSITIONS FOR RETINAL DRUG DELIVERY

ANTI-BCMA CAR T CELL COMPOSITIONS

ANTI-BCMA CAR T CELL COMPOSITIONS

DEVICES AND METHODS TO TREAT AND PREVENT DIVERTICULITIS

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

METHODS OF TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE

COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC LUNG DISEASES

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

FUSED RING COMPOUNDS

TREATMENT OF HYPERTENSION BY RENAL VASCULAR DELIVERY OF GUANETHIDINE

OLIGOSACCHARIDE COMPLEXES AND USES

METHODS OF TREATING TUMORS

COMBINATION THERAPY WITH ARENAVIRUS PARTICLES AND IMMUNE CHECKPOINT MODULATORS OR CYTOKINES

SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES

Improved Lyophilized Formulation

COMPOSITIONS AND METHODS OF MODULATING HIF-2A TO IMPROVE MUSCLE GENERATION AND REPAIR

METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS

READY-TO-DILUTE FORMULATION

AQUEOUS PARENTERAL PHARMACEUTICAL FORMULATIONS CONTAINING 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES

PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION

STABLE LEVOTHYROXINE COMPOSITIONS IN APROTIC POLAR SOLVENTS

METHODS AND COMPOSITIONS FOR REDUCING SYMPTOMS OF PARKINSON'S DISEASE

AN INJECTABLE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES IN ANIMALS

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

COMPOSITIONS, METHODS AND USES OF MESSENGER RNA

FORMULATIONS AND DOSES OF PEGYLATED URICASE

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

Carboxyalkyl Chitosan

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

GIP/GLP1 CO-AGONIST COMPOUNDS

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

METHOD FOR SOLUBILIZING 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE

Needle Assisted Injection Device Having Reduced Trigger Force

BIOORTHOGONAL COMPOSITIONS

DOSING REGIMENS FOR SELECTIVE TREG STIMULATOR RUR20kD-IL-2 AND RELATED COMPOSITIONS

PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED BETACYCLODEXTRINS

NOVEL COMPOSITION

MICRORNA-BASED PARTICLE FOR THE TREATMENT OF DYSREGULATED IMMUNE RESPONSE

TETRACYCLINE COMPOSITIONS

METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION

FORMULATIONS, METHODS, KITS, AND DOSAGE FORMS

Compositions and Methods of Treating Cardiac Fibrosis with Ifetroban

CYCLIC NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF

L-THEANINE AND TETRAHYDROCANNABINOL FORMULATION

HIGH-EFFICIENCY AND LOW-TOXICITY DNA AND RNA LIPID DELIVERY CARRIER

AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY

LIPID ANALOGS AND LIPOSOMES COMPRISING SAME

FORMULATION OF HIGHLY CONCENTRATED PHARMACOLOGICALLY ACTIVE ANTIBODY

HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE

NON-INTEGRATING VIRAL DELIVERY SYSTEM AND METHODS RELATED THERETO

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

PHARMACEUTICAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS

Injectable Medical Formulation for Spinal Anesthesia, Process of Preparing, and Process of Administering

MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL, A METHOD FOR TREATING A SUBJECT IN NEED OF TREATMENT OF BODY WITH IMPLANTABLE MATERIAL AND A METHOD FOR MANUFACTURING THE MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY